MedVi vs BreezeMeds: Promo Price and Medication Options Compared

Quick verdict: For a lower promotional first month and a fully online, no-clinic process, MedVi is the clearer choice; BreezeMeds stands out if you need injectable or oral tirzepatide options and a broader product menu. This comparison of MedVi vs BreezeMeds summarizes the main differences so you can decide which fits your needs.

Start MedVi intake at $179 first month

MedVi vs BreezeMeds: overview and early verdict

Both platforms use online intake and clinician review, but they differ most on promotional pricing, medication options, and how they describe medication status. MedVi advertises compounded semaglutide starting at $179/month with 24/7 certified medical support and no clinic visits. BreezeMeds displays semaglutide injection starting at $199/mo and explicitly lists tirzepatide injection from $299 and oral options from $399, with discreet home delivery.

Key differences to compare

1. Price structure and promotions

MedVi promotes a winter first-month price of $179 including fast, free shipping, with ongoing standalone months at $299 and a three-month plan at $649. BreezeMeds shows a range: semaglutide injection from $199, tirzepatide injection from $299, and oral options from $399, plus a separate $169 figure that is not clearly tied to a product.

2. Medication selection

MedVi focuses on compounded semaglutide only, with no branded Ozempic or Wegovy offered on its platform and no tirzepatide option. BreezeMeds lists both semaglutide and tirzepatide injections and also shows oral semaglutide and oral tirzepatide options, indicating a broader medication menu.

3. Compounding and regulatory notes

MedVi explicitly states it offers clinically dosed compounded semaglutide and includes the regulatory qualification that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. BreezeMeds notes that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable, and says compounding status requires confirmation.

4. Process, support, and delivery

MedVi emphasizes a simple online process with no clinic visits and 24/7 support from certified medical professionals. MedVi also notes medication is filled at a licensed pharmacy and shipped to your door with fast, free shipping on the promo. BreezeMeds highlights online intake, a personalized treatment plan, and discreet home delivery with ongoing support, but captured evidence shows some fee and state availability details were not fully visible.

Open MedVi program details

Comparison table: MedVi vs BreezeMeds

What is and is not supported in the source

The supplied evidence documents MedVi’s promotional price of $179 for the first month, its focus on compounded semaglutide, 24/7 certified medical support, and a no-clinic online process. BreezeMeds evidence shows semaglutide from $199, tirzepatide injection from $299, and oral options from $399, with discreet home delivery. The source materials do not provide comprehensive state availability, full fee schedules for BreezeMeds, or outcome guarantees for either provider beyond the linked statements and qualifiers.

Choosing between MedVi and BreezeMeds

Choose MedVi if you want the lowest documented promotional first month for compounded semaglutide, a completely online no-clinic path, and 24/7 certified medical support. Choose BreezeMeds if you need access to injectable or oral tirzepatide options or a broader list of medication formats and are willing to confirm pricing, renewal terms, and product status during intake.

Begin MedVi intake

This comparison used only supplied evidence. MedVi vs BreezeMeds differences above reflect captured pricing, medication menus, support claims, and regulatory qualifiers from each provider’s materials.